slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 15,841-15,870
Pages 819
Rows per page 30
Slide function
15,841-15,870 of 24,547
54
The slide uses a linear process flow to describe a drug discovery pipeline.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
55
The chart illustrates a Pareto front analysis in drug discovery, highlighting the selection of compounds that are not necessarily 'optimal' by standard metrics but provide high information value.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
57
The slide uses two distinct chart types (dot plot and line chart) to contrast the safety profiles of reversible vs irreversible LSD1 inhibitors.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
59
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
61
The background features a 3D molecular visualization, likely representing the MALT1 protein structure.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
62
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
64
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
65
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
67
The slide outlines a multi-stage pipeline: Initiate, Analyse, Evolve, 2D Models, 3D Models, and Active Learning.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
68
The slide highlights the technical methodology behind a specific drug candidate ('565) using molecular dynamics.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
70
The chart shows tumor volume over time (D20-D30) for various treatment groups, highlighting the superior performance of the combination therapy.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
31
The slide uses a circular diagram to represent the client-centric service model.First Busey | Results Presentation Deck | 41 slides · First Busey Corporation
Deck Investor relations Loop · Golden Circle1 hit
09
The slide uses a list-based structure to define market segments and corresponding strategic objectives.First Foundation | Investor Presentation Deck | 48 slides · First Foundation
Conference presentation Investor relations Beat · Solution1 hit
10
Uses a custom process flow to map generations to financial goals (Educate/Protect, Plan/Build, Consume/Distribute).First Foundation | Investor Presentation Deck | 48 slides · First Foundation
Conference presentation Investor relations Beat · ProductLoop · Voice Of Customer1 hit
03
The slide uses a collage of imagery representing political, legislative, and data-driven environments to reinforce the 'What We Do' statement.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · Solution1 hit
04
FiscalNote | Investor Presentation Deck | 32 slidesFiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations 1 hit
11
FiscalNote | Investor Presentation Deck | 32 slidesFiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · ProductLoop · Quick Win Big Bet1 hit
12
The slide uses a process flow diagram to illustrate the company's proprietary data infrastructure.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
14
The left side uses a tree metaphor to show the foundation (AI/ML/NLP) supporting various research and compliance applications. The right side uses an icon grid to list target sectors.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The left chart is a conceptual diagram showing ACV growth based on user count and product usage. The right chart shows specific ARR growth metrics for two customers.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
04
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
06
Uses a process diagram to illustrate the transition from cold to hot tumor states.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
07
The central diagram illustrates the biological mechanism of action, contrasting the absence vs. presence of effector T cells.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a pyramid diagram to represent the evolution of oncolytic virus technology, with Genelux's platform at the top.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
25
The slide highlights physical assets and operational capacity.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Market Size1 hit
27
The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
28
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
38
The slide uses clinical study data (VIRO-15, NCT01443260) to support its claims about immune modulation.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit
04
The slide uses a structured table-like layout to present scientific rationale (Background, Opportunity, Target Validation) followed by a summary box for the lead asset.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
08
The diagram illustrates the binding mechanism of the antibody to the cell surface receptors.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit